Laporan Laba Rugi (TTM)
Laporan Laba Rugi Revolution Medicines, Inc. - Equity Warrant menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 46 | 43 | 42 | 40 | 29 | 29 | 27 | 27 | 30 | 35 | 35 | 30 | 26 | 12 | 5 | 1 | 1 |
| Change (%) | -7.20 | -3.29 | -3.19 | -28.73 | 2.47 | -8.69 | 1.56 | 8.27 | 19.89 | -1.59 | -15.20 | -11.37 | -55.75 | -60.57 | -83.75 | 0.00 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 123 | 132 | 146 | 159 | 170 | 187 | 203 | 218 | 241 | 253 | 266 | 149 | 341 | 411 | 460 | 421 | 541 |
| Change (%) | 7.75 | 10.13 | 8.94 | 7.31 | 9.79 | 8.36 | 7.44 | 10.56 | 5.17 | 4.92 | -43.91 | 128.83 | 20.67 | 11.93 | -8.56 | 28.46 | |
| % of Revenue | 264.97 | 307.68 | 350.40 | 394.30 | 593.68 | 636.09 | 754.85 | 798.55 | 815.41 | 715.30 | 762.67 | 504.42 | 1,302.32 | 3,551.33 | 10,081.43 | 56,728.03 | 72,871.97 |
| Gross Operating Profit | -76 | -89 | -104 | -118 | -142 | -158 | -176 | -190 | -211 | -218 | -231 | -119 | -315 | -400 | -456 | -420 | -540 |
| Change (%) | 16.82 | 16.60 | 13.78 | 19.56 | 11.28 | 11.54 | 8.33 | 10.89 | 3.11 | 5.98 | -48.25 | 163.50 | 27.03 | 14.03 | -7.81 | 28.51 | |
| % of Revenue | -164.97 | -207.68 | -250.40 | -294.30 | -493.68 | -536.09 | -654.85 | -698.55 | -715.41 | -615.30 | -662.67 | -404.42 | -1,202.32 | -3,451.33 | -9,981.43 | -56,628.03 | -72,771.97 |
| SG&A | 20 | 21 | 23 | 25 | 28 | 30 | 33 | 36 | 38 | 41 | 45 | 49 | 54 | 62 | 72 | 79 | 88 |
| Change (%) | 8.41 | 7.00 | 9.62 | 9.75 | 10.39 | 7.77 | 8.86 | 7.40 | 5.78 | 10.32 | 9.91 | 10.32 | 14.25 | 15.50 | 9.87 | 11.46 | |
| % of Revenue | 42.67 | 49.85 | 55.16 | 62.46 | 96.17 | 103.61 | 122.28 | 131.08 | 130.02 | 114.71 | 128.60 | 166.67 | 207.46 | 535.59 | 1,568.88 | 10,607.28 | 11,823.32 |
| R&D | 154 | 76 | |||||||||||||||
| Change (%) | |||||||||||||||||
| % of Revenue | 520.21 | 10,289.35 | |||||||||||||||
| OpEx | 143 | 154 | 169 | 184 | 198 | 217 | 235 | 253 | 279 | 294 | 310 | 352 | 395 | 473 | 532 | 576 | 628 |
| Change (%) | 7.84 | 9.70 | 9.03 | 7.65 | 9.88 | 8.28 | 7.64 | 10.11 | 5.26 | 5.67 | 13.35 | 12.33 | 19.79 | 12.40 | 8.28 | 9.11 | |
| % of Revenue | 307.64 | 357.54 | 405.55 | 456.76 | 689.85 | 739.70 | 877.14 | 929.63 | 945.43 | 830.01 | 891.27 | 1,191.30 | 1,509.77 | 4,086.92 | 11,650.31 | 77,624.66 | 84,695.28 |
| Operating Income | -96 | -111 | -127 | -144 | -169 | -188 | -209 | -226 | -249 | -258 | -275 | -322 | -369 | -462 | -527 | -575 | -628 |
| Change (%) | 15.09 | 14.74 | 13.03 | 17.84 | 11.13 | 10.93 | 8.42 | 10.34 | 3.52 | 6.66 | 16.95 | 14.50 | 25.15 | 14.23 | 9.07 | 9.12 | |
| % of Revenue | -207.64 | -257.54 | -305.55 | -356.76 | -589.85 | -639.70 | -777.14 | -829.63 | -845.43 | -730.01 | -791.27 | -1,091.30 | -1,409.77 | -3,986.92 | -11,550.31 | -77,524.66 | -84,595.28 |
| Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 | 0 | 0 | 0 | -0 | -0 | -0 | -0 | ||||
| Change (%) | -11.25 | -12.68 | -30.65 | -39.53 | -53.85 | -100.00 | NaN | NaN | -0.00 | -0.00 | -0.00 | ||||||
| % of Revenue | -0.17 | -0.17 | -0.15 | -0.11 | -0.09 | -0.04 | 0.00 | 0.00 | 0.00 | -2.62 | -6.64 | -40.84 | -40.84 | ||||
| Net Income | -89 | -108 | -126 | -143 | -169 | -187 | -208 | -224 | -245 | -249 | -259 | -296 | -331 | -436 | -484 | -519 | -567 |
| Change (%) | 22.14 | 16.33 | 13.58 | 18.00 | 10.95 | 10.94 | 8.15 | 9.08 | 1.56 | 4.20 | 14.31 | 11.85 | 31.70 | 10.98 | 7.21 | 9.22 | |
| % of Revenue | -191.17 | -251.63 | -302.68 | -355.11 | -587.91 | -636.58 | -773.42 | -823.65 | -829.80 | -702.95 | -744.36 | -1,003.36 | -1,266.19 | -3,768.28 | -10,606.04 | -69,973.99 | -76,423.32 |
Source: Capital IQ
